is 30 units of semaglutide a lot FDA alerts health care providers, compounders and patients dosing errors associated with compounded injectable products is 30 units of semaglutide

These symptoms typically improve within 4-8 weeks as the body adjusts to treatment

Cross-Sectional Analysis of Adverse Dermatologic Events Reported to the FDA After Use of GLP-1 Agonists

However, both compounds individually cause: Nausea (60-80% of users at higher doses) Vomiting (20-35%) Diarrhea (25-40%) Injection site reactions (15-25%) Potential pancreatitis (rare but serious) Combining these compounds could theoretically amplify these effects, though the actual incidence and severity remain unstudied

The answer is regulatory structure, not quality shortcuts - though the two are related in ways worth understanding

FDA-approved semaglutide from Novo Nordisk undergoes rigorous manufacturing controls, batch testing, stability studies, and quality assurance processes mandated by the FDA

The increase in use of GLP-1s is alarming for two reasons: (1) The first reason that the increase in use of GLP-1 drugs is concerning is their little-known long-term side effects and potentially unknown short-term side effects